Cough Syrup DM

Product NDC
35418-119
11-digit product format
354180119
Labeler code
35418
Product ID
35418-119_f19c0138-c1bc-9420-e053-2995a90a0e59
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin, Dextromethorpham HBr
Dosage form
SYRUP
Route
ORAL
Labeler
Zee Medical Inc
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2012-06-12
Marketing end
2023-03-01
Substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Active strength
10 mg/5mL; mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct35418-119DDiscontinued by firm2026-10-05
excluded packagepackage35418-11935418-119-37DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 32 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage35418-119-37DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage35418-119-37DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage35418-119-37DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage35418-119-37DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage35418-119-37DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage35418-119-37DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage35418-119-37DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage35418-119-37DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage35418-119-37DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductDDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage35418-119-37DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductDDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage35418-119-37DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductDDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage35418-119-37DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductIInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage35418-119-37IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproductIInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage35418-119-37IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductIInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage35418-119-37IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproductIInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage35418-119-37IInactivated by FDA8dfbde2a14a4…c9ff85d89658…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
35418-119-372023-01-06C16284748780-1ba0f9c33-1485-a910-e053-dadaa90a0b85Drug Facts
35418-119-372021-01-29C16284748780-1ba0f9c33-1485-a910-e053-dadaa90a0b85Drug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DEXTROMETHORPHAN HYDROBROMIDEACTIVE INGREDIENT9D2RTI9KYHCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
GUAIFENESINACTIVE INGREDIENT495W7451VQCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
DEXTROMETHORPHANACTIVE MOIETY7355X3ROTSCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
GUAIFENESINACTIVE MOIETY495W7451VQCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOACOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3COUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD4COUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1
WATERINACTIVE INGREDIENT059QF0KO0RCOUGH SYRUP DM (GUAIFENESIN, DEXTROMETHORPHAM HBR) SYRUP [ZEE MEDICAL INC]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
35418-119-37354180119376 PACKET in 1 CARTON (35418-119-37) > 10 mL in 1 PACKET (35418-119-42) 6 packet2012-06-122023-03-01NoNoCurrent